Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough
D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith
{"title":"Rationale and Design of Two, Phase 3, Randomized Controlled Trials (COUGH-1 and COUGH-2) of Gefapixant, A P2x3 Receptor Antagonist, in Refractory and Unexplained Chronic Cough","authors":"D. Muccino, A. Morice, S. Birring, L. Mcgarvey, P. Dicpinigaitis, I. Pavord, A. Tershakovec, M. Kitt, Y. Zheng, C. Assaid, Jacky A. Smith","doi":"10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":160937,"journal":{"name":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","volume":"305 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2019-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"C37. SYMPTOMS, PLEURAL DISEASE, BEHAVIORAL SCIENCE, AND OTHER TOPICS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4700","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
